Therefore, in the present study, the effects of bortezomib treatment on the stabilization of HIF-2α and corresponding HIF-2 activity were examined using cancer cell lines known to express both HIF-1α and HIF-2α, and a cancer cell line expressing only HIF-2α. This evidence concerns the gene HIF1A and cancer.